Zyus Life Sciences Corp (ZYUS)

Currency in CAD
0.700
-0.030(-4.11%)
Closed·
ZYUS Scorecard
Full Analysis
Quickly burning through cash
ZYUS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.7000.700
52 wk Range
0.5501.000
Key Statistics
Bid/Ask
0.61 / 0.73
Prev. Close
0.7
Open
0.7
Day's Range
0.7-0.7
52 wk Range
0.55-1
Volume
4K
Average Volume (3m)
12.14K
1-Year Change
-30%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ZYUS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.500
Upside
+114.29%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Zyus Life Sciences Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Zyus Life Sciences Corp Company Profile

ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2 clinical trial for the treatment of chronic pain in adults caused due to musculoskeletal injuries, arthritis, and cancer. ZYUS Life Sciences Corporation was founded in 2018 and is headquartered in Saskatoon, Canada.

Compare ZYUS to Peers and Sector

Metrics to compare
ZYUS
Peers
Sector
Relationship
P/E Ratio
−1.7x−0.4x−0.6x
PEG Ratio
−0.060.000.00
Price/Book
−7.6x0.9x2.6x
Price / LTM Sales
118.6x0.7x3.3x
Upside (Analyst Target)
105.5%11.5%39.0%
Fair Value Upside
Unlock13.6%4.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 1.500
(+114.29% Upside)

Earnings

Latest Release
May 29, 2025
EPS / Forecast
-0.05 / --
Revenue / Forecast
114.00K / --
EPS Revisions
Last 90 days

ZYUS Income Statement

FAQ

What Stock Exchange Does Zyus Life Sciences Trade On?

Zyus Life Sciences is listed and trades on the TSX Venture Exchange stock exchange.

What Is the Stock Symbol for Zyus Life Sciences?

The stock symbol for Zyus Life Sciences is "ZYUS."

What Is the Zyus Life Sciences Market Cap?

As of today, Zyus Life Sciences market cap is 57.05M.

What Is Zyus Life Sciences's Earnings Per Share (TTM)?

The Zyus Life Sciences EPS (TTM) is -0.47.

From a Technical Analysis Perspective, Is ZYUS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Zyus Life Sciences Stock Split?

Zyus Life Sciences has split 0 times.

How Many Employees Does Zyus Life Sciences Have?

Zyus Life Sciences has 0 employees.

What is the current trading status of Zyus Life Sciences (ZYUS)?

As of 26 Aug 2025, Zyus Life Sciences (ZYUS) is trading at a price of 0.70, with a previous close of 0.70. The stock has fluctuated within a day range of 0.70 to 0.70, while its 52-week range spans from 0.55 to 1.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.